107 related articles for article (PubMed ID: 28214211)
1. Expression of BMP-4 in papillary thyroid carcinoma and its correlation with tumor invasion and progression.
Meng X; Zhu P; Li N; Hu J; Wang S; Pang S; Wang J
Pathol Res Pract; 2017 Apr; 213(4):359-363. PubMed ID: 28214211
[TBL] [Abstract][Full Text] [Related]
2. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
Jiang XL; Zhang H; Chen YL; Peng L
Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
[No Abstract] [Full Text] [Related]
3. Disparity expression of gammaH2AX in papillary thyroid cancer and nodular goiter.
Hu S; Zhang G; Xu J; Zhu X; Lu X; Jiang L; Wang Q; Hou X; Cao J; Ge M
Clin Lab; 2014; 60(12):2031-7. PubMed ID: 25651738
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of survivin expression and its prognostic value in papillary thyroid carcinoma.
Selemetjev S; Dencic TI; Marecko I; Jankovic J; Paunovic I; Savin S; Cvejic D
Pathol Res Pract; 2014 Jan; 210(1):30-4. PubMed ID: 24199968
[TBL] [Abstract][Full Text] [Related]
5. TROP-2 immunohistochemistry: a highly accurate method in the differential diagnosis of papillary thyroid carcinoma.
Bychkov A; Sampatanukul P; Shuangshoti S; Keelawat S
Pathology; 2016 Aug; 48(5):425-33. PubMed ID: 27311870
[TBL] [Abstract][Full Text] [Related]
6. [The study of the correlation of papillary thyroid carcinoma's invasion toward Ezrin and E-cadherin].
Liu C; Chen X; Gao Z; Liu Z; Tao X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Sep; 26(17):789-91, 795. PubMed ID: 23214316
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of estrogen receptor β2 is associated with different biological markers and clinicopathological factors in papillary thyroid cancer.
Dong W; Li J; Zhang H; Huang Y; He L; Wang Z; Shan Z; Teng W
Int J Clin Exp Pathol; 2015; 8(6):7149-56. PubMed ID: 26261608
[TBL] [Abstract][Full Text] [Related]
8. [Study of the correlation of papillary thyroid carcinoma's invasion with Ezrin, Moesin and E-Cadherin].
Tao XF; Liu C; Bai Y; Chen X
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Sep; 46(9):761-3. PubMed ID: 22177047
[TBL] [Abstract][Full Text] [Related]
9. [Expression and clinical significance of Muc1, p63 protein in diffuse sclerosing variant of papillary thyroid carcinoma and conventional papillary thyroid carcinoma].
Hao Y; Jin C; Wang J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 May; 27(9):457-61. PubMed ID: 23898609
[TBL] [Abstract][Full Text] [Related]
10. [Relationship between activated STAT3 protein and epithelial-mesenchymal transition in papillary thyroid carcinoma].
Zhang Z; Bai Y; Li P; Zhao J; Wang Y; Sun L; Tang J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov; 27(22):1265-8. PubMed ID: 24616987
[TBL] [Abstract][Full Text] [Related]
11. Activation of the ROCK1/MMP-9 pathway is associated with the invasion and poor prognosis in papillary thyroid carcinoma.
Luo D; Chen H; Li X; Lu P; Long M; Peng X; Lin S; Tan L; Zhu Y; Ouyang N; Li H
Int J Oncol; 2017 Oct; 51(4):1209-1218. PubMed ID: 28848996
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of cytokeratin 17 is associated with the development of papillary thyroid carcinoma and the presence of lymph node metastasis.
Kim HS; Lee JJ; Do SI; Kim K; Do IG; Kim DH; Chae SW; Sohn JH
Int J Clin Exp Pathol; 2015; 8(5):5695-701. PubMed ID: 26191283
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic significance of elevated expression of HBME-1 in papillary thyroid carcinoma.
Chen YJ; Zhao RM; Zhao Q; Li BY; Ma QY; Li X; Chen X
Tumour Biol; 2016 Jul; 37(7):8715-20. PubMed ID: 26738867
[TBL] [Abstract][Full Text] [Related]
14. Papillary thyroid carcinoma with bone formation.
Na KY; Kim HS; Lee SK; Jung WW; Sung JY; Kim YW; Park YK
Pathol Res Pract; 2013 Jan; 209(1):14-8. PubMed ID: 23177617
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of G Protein-Coupled Receptor Kinase 6 (GRK6) Is Associated with Progression and Poor Prognosis of Papillary Thyroid Carcinoma.
Che X; Zhang G; Zhang X; Xue J
Med Sci Monit; 2018 May; 24():3540-3548. PubMed ID: 29805156
[TBL] [Abstract][Full Text] [Related]
16. LGR5 is associated with tumor aggressiveness in papillary thyroid cancer.
Michelotti G; Jiang X; Sosa JA; Diehl AM; Henderson BB
Oncotarget; 2015 Oct; 6(33):34549-60. PubMed ID: 26416247
[TBL] [Abstract][Full Text] [Related]
17. Expression of HIF-1α/PKM2 axis correlates to biological and clinical significance in papillary thyroid carcinoma.
Hao Z; Wang Y; Li J; Liu W; Zhao W; Wang J
Medicine (Baltimore); 2023 Mar; 102(10):e33232. PubMed ID: 36897686
[TBL] [Abstract][Full Text] [Related]
18. The involvement of CXCR7 in modulating the progression of papillary thyroid carcinoma.
Liu Z; Yang L; Teng X; Zhang H; Guan H
J Surg Res; 2014 Oct; 191(2):379-88. PubMed ID: 24814201
[TBL] [Abstract][Full Text] [Related]
19. Predictive factors of contralateral paratracheal lymph node metastasis in unilateral papillary thyroid carcinoma.
Wei T; Chen R; Zou X; Liu F; Li Z; Zhu J
Eur J Surg Oncol; 2015 Jun; 41(6):746-50. PubMed ID: 25882035
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of HIF-1α, metallothionein and SLUG is associated with high TNM stage and lymph node metastasis in papillary thyroid carcinoma.
Wang N; Dong CR; Jiang R; Tang C; Yang L; Jiang QF; Chen GG; Liu ZM
Int J Clin Exp Pathol; 2014; 7(1):322-30. PubMed ID: 24427353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]